×
AllNewsImagesShopping Maps Videos Books
Search tools

Dexcom continues advances in AI for CGM, type 2 diabetes awareness

Drug Delivery Business
One of the leaders in continuous glucose monitoring (CGM) technology, Dexcom (Nadsaq:DXCM) continues to expand its capabilities.
1 day ago

Diabetes Dialogue: Updates from Dexcom at ADA 2025, with Kevin Sayer

HCPLive
Kevin Sayer joins the program to discuss the latest from Dexcom and preview where the business is headed in an evolving diabetes landscape.
1 day ago

Dexcom recalls more than 2 million CGM receivers for lack of audible alarm

MedTech Dive
Severe adverse events, including seizure and loss of consciousness, were potentially linked to the issue, based on 56 reports Dexcom...
5 days ago

Dexcom shares U.S. report on CGM benefits for type 2 diabetes

MassDevice
Dexcom (Nasdaq:DXCM) has shared a new report highlighting access and attitudes toward type 2 diabetes in the U.S..
2 days ago

Piper Sandler sees strong CGM market benefiting Dexcom, Abbott

Investing.com
Investing.com - Piper Sandler highlighted growth opportunities in the continuous glucose monitoring (CGM) market following the American...
23 hours ago

Dexcom recalls more than 2 million CGM receivers over safety issues—dozens of adverse events reported

Cardiovascular Business
Dexcom has issued four separate recalls for its continuous glucose monitoring (CGM) systems due to audio issues that could result in missed...
5 days ago

New Android 16 update could impact Dexcom G6 mobile app usage, Dexcom warns

Diabetes UK
If you do not download the new Android 16 update then you will not be affected, and Dexcom G7 users are not affected. Android 16 update...
4 days ago

Dexcom replaces handheld CGM receivers after missed audio alerts

Fierce Biotech
A defective speaker resulted in some Dexcom G7, G6 and One CGM users missing audio alarms for unhealthy blood sugar levels.
6 days ago

Stelo Files Complaint Against Dexcom, Inc. for Trademark Infringement, Negligence, Unfair Competition

RochesterFirst
SAN FRANCISCO, June 23, 2025 /PRNewswire/ -- Stelo, an enterprise software company, has filed suit in Federal District Court for the Central...
1 day ago

Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System

Dexcom
The FDA has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes in the United States.
2 months ago